In combination, the average expression of the 20 genes showed significantly higher expression in the Basal subtype compared to Luminal A and B breast cancer subtypes but lower in the HER2 subtype (Supplementary Fig. 3d). This evidence concerns the gene ERBB2 and breast cancer.